Futura Medical (FUM)

Sector:

Pharma and Biotech

Index:

FTSE AIM All-Share

9.90p
   
  • Change Today:
      0.100p
  • 52 Week High: 41.30
  • 52 Week Low: 9.02
  • Currency: UK Pounds
  • Shares Issued: 303.83m
  • Volume: 209,110
  • Market Cap: £30.08m
  • RiskGrade: 479
  • Beta: 0.01

Growth Ratings

EPS Growth shows the relative growth of a company's earnings over the last year.

The rise in total monies receivable for goods / services sold before expenses.

1yr EPS Growth Not Available
1yr Revenue Growth Not Available

Income Ratings

The percentage of the share price that a company pays out as dividends over a year.

The percentage change from the previous year in the dividend paid on each share.

Dividend Yield Not Available
1yr DPS Growth Not Available

Valuation Ratings

The share price as a ratio of revenue per share.

The share price as a ratio of net asset value.

Price Sales Ratio
41.55% above the market average41.55% above the market average41.55% above the market average41.55% above the market average41.55% above the market average
50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average50.00% above the sector average
Price Book Ratio
85.26% below the market average85.26% below the market average85.26% below the market average85.26% below the market average85.26% below the market average
57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average57.14% below the sector average

Performance Ratings

In percentage total change in share price over 30 days.

In percentage total change in share price over 3 months.

Price Chg 30d
55.44% below the market average55.44% below the market average55.44% below the market average55.44% below the market average55.44% below the market average
16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average16.67% below the sector average
Price Chg 3m
98.33% below the market average98.33% below the market average98.33% below the market average98.33% below the market average98.33% below the market average
91.67% below the sector average91.67% below the sector average91.67% below the sector average91.67% below the sector average91.67% below the sector average

Technical Ratings

The Relative Strength Index measures a share price relative to itself and its recent history.

Momentum is an oscillator that measures the rate of price change.

RSI
3.08% above the market average3.08% above the market average3.08% above the market average3.08% above the market average3.08% above the market average
2.22% above the sector average2.22% above the sector average2.22% above the sector average2.22% above the sector average2.22% above the sector average
Momentum 20
0.93% above the market average0.93% above the market average0.93% above the market average0.93% above the market average0.93% above the market average
24.44% below the sector average24.44% below the sector average24.44% below the sector average24.44% below the sector average24.44% below the sector average

Management Ratings

Operating Margin is profit as a percentage of sales.

Return on capital employed measures the return from invested and borrowed capital.

Operating Margin
81.56% below the market average81.56% below the market average81.56% below the market average81.56% below the market average81.56% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average
ROCE Not Available

Profitability Ratings

Earnings per share, the company's profitability expressed on a per share basis.

Analysts' estimates of future EPS for the next 2 years.

EPS
65.8% below the market average65.8% below the market average65.8% below the market average65.8% below the market average65.8% below the market average
23.4% below the sector average23.4% below the sector average23.4% below the sector average23.4% below the sector average23.4% below the sector average
Forecast EPS
96.65% below the market average96.65% below the market average96.65% below the market average96.65% below the market average96.65% below the market average
100% below the sector average100% below the sector average100% below the sector average100% below the sector average100% below the sector average

Profit/Loss Ratings

Monies produced from sales of goods and services after trade discounts, VAT, etc.

Operating Profit is the profit after deducting operating costs from gross profits.

Turnover
63.95% below the market average63.95% below the market average63.95% below the market average63.95% below the market average63.95% below the market average
25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average25.71% below the sector average
Operating Profit Loss
79.28% below the market average79.28% below the market average79.28% below the market average79.28% below the market average79.28% below the market average
31.91% below the sector average31.91% below the sector average31.91% below the sector average31.91% below the sector average31.91% below the sector average

Balance Sheet Ratings

The difference between current assets and current liabilities.

A current asset representing the company's financial liquidity.

Assets
35.33% below the market average35.33% below the market average35.33% below the market average35.33% below the market average35.33% below the market average
6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average6.67% below the sector average
Cash
4.3% below the market average4.3% below the market average4.3% below the market average4.3% below the market average4.3% below the market average
13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average13.04% above the sector average

Director Deal Ratings

The cumulative amount of stocks sold by company directors over 1 year

The cumulative amount of stocks bought by company directors over 1 year

Sells 1y
26.93% below the market average26.93% below the market average26.93% below the market average26.93% below the market average26.93% below the market average
50% below the sector average50% below the sector average50% below the sector average50% below the sector average50% below the sector average
Buys 1y
21.81% above the market average21.81% above the market average21.81% above the market average21.81% above the market average21.81% above the market average
11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average11.11% below the sector average

Broker Ratings

The percentage of stockbrokers that rate the company as a Buy

The percentage of stockbrokers that rate the company as a Hold

Brokers Percent Buy
65.97% above the market average65.97% above the market average65.97% above the market average65.97% above the market average65.97% above the market average
75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average75.00% above the sector average
Brokers Percent Neutral Not Available

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

Futura Medical Market Data

Currency UK Pounds
Share Price 9.90p
Change Today 0.100p
% Change 1.02 %
52 Week High 41.30
52 Week Low 9.02
Volume 209,110
Shares Issued 303.83m
Market Cap £30.08m
Beta 0.01
RiskGrade 479

Futura Medical Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
80% below the market average80% below the market average80% below the market average80% below the market average80% below the market average
70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average70.21% below the sector average
Price Trend
92.42% below the market average92.42% below the market average92.42% below the market average92.42% below the market average92.42% below the market average
75% below the sector average75% below the sector average75% below the sector average75% below the sector average75% below the sector average
Income Not Available
Growth Not Available

What The Brokers Say

Strong Buy 1
Buy 1
Neutral 0
Sell 0
Strong Sell 0
Total 2
strong_buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Futura Medical Dividends

No dividends found

Trades for 11-Apr-2025

Time Volume / Share Price
15:15 20,000 @ 9.80p
14:52 1,385 @ 9.63p
13:13 2,500 @ 9.80p
12:54 15,255 @ 9.80p
12:49 10,000 @ 9.51p

Futura Medical Key Personnel

CEO James Henry Barder
Finance Director Angela Hildreth

Top of Page